Objective: Aortic reconstruction for complex thoracoabdominal aortic aneurysms (TAAAs) can be challenging, especially in patients with connective tissue disorders (CTDs) in whom tissue fragility is a major concern. Branched graft reconstruction is a more complex operation compared with inclusion patch repair of the aorta but is frequently necessary in patients with CTDs or other pathologies because of anatomic reasons. We describe our institutional experience with open branched graft reconstruction of aortic aneurysms and compare outcomes for patients with CTDs vs degenerative pathologies.
Aortic reconstruction for complex thoracoabdominal aortic aneurysms (TAAAs) can be challenging, especially when the visceral or renal arteries are involved in the repair. Visceral-renal involvement is most commonly treated using the Crawford inclusion technique, whereby the vessels are included into the aortic graft via the use of a Carrel patch. 1 However, this technique carries a risk of patch aneurysm formation, especially in patients with connective tissue disorders (CTDs). Secondary procedures to repair patch aneurysms are especially hazardous. CTDs are a group of diseases characterized by mutations in collagen and elastin molecules that lead to a spectrum of somatic manifestations. The cardiovascular phenotypes that occur are the result of disordered homeostasis of collagen and elastin maintenance in the vascular wall, and patients commonly present with ; the Section of Vascular dilation of the aortic root, aortic dissection and, eventually, aneurysmal degeneration of the entire aorta. 2 Aortic root repair and replacement of the aneurysmal ascending aorta have led to improvements in survival in patients with CTDs. 3 Thus, more CTD patients are surviving to require intervention on the thoracoabdominal aorta through their lifespan. Although open TAAA repairs have been reported in patients with CTD with good outcomes, 4 the risk of visceral patch aneurysm has been shown to be nearly three-times higher than in the general population. 1 One solution for this problem is to perform the aortic repair using branch graft reconstruction of the involved visceral or renal arteries. 5 Branched graft reconstruction for
TAAAs is a more complex operation than inclusion patch repair but may reduce the risk of visceral patch aneurysm in patients with CTD. 6 The technique can also be applied to non-CTD patients with widely spaced visceral or renal involvement that would preclude them from the use of a traditional inclusion patch. 7 We recently described our technique of branched graft aortic reconstruction and reported favorable outcomes in a small group of patients with CTD. 6 However, the outcomes of open branched graft reconstruction of aortic aneurysms for patients with CTD vs non-CTD aneurysms is unknown. The current study describes our institution's experience with branched graft reconstruction of aortic aneurysms and compares perioperative and midterm outcomes among patients undergoing this technique for aneurysms related to CTD vs degenerative pathologies.
METHODS
Cohort. We retrospectively analyzed all patients undergoing open thoracoabdominal aortic reconstruction (type I-IV) with concomitant visceral or renal artery, or both, branched grafts at our institution between July 1, 2006 , and December 31, 2015. Patients were identified from a list of open TAAA repairs that is prospectively maintained by the operating surgeons at our institution. The analysis excluded patients undergoing TAAA repair without visceral-renal artery reconstruction by beveled distal anastomosis across visceral aorta (n ¼ 28), those who underwent TAAA repair with Carrel patch (n ¼ 7), and those who underwent staged debranching, followed by endovascular TAAA repair (n ¼ 4). The Johns Hopkins Institutional Review Board approved this study. Informed consent was waived due to the retrospective nature of the data collection.
Demographics, comorbidities, surgical history, perioperative details (including technical details and postoperative complications), and surgical outcomes were collected for all included patients. Comorbid conditions analyzed included hypertension (defined as requiring $1 antihypertensive medications to maintain blood pressure <140/90 mm Hg), chronic obstructive pulmonary disease (defined as repeated diagnoses of bronchitis, abnormal pulmonary function tests, or daily need for daily inhaler treatment, or all), coronary artery disease (defined as history of angina, percutaneous coronary intervention, or coronary artery bypass, or all), diabetes (defined as requiring oral antihyperglycemic drugs or insulin therapy, or both), congestive heart failure (as defined by the American Heart Association 8 ), and chronic renal insufficiency (defined as a glomerular filtration rate of <90 mL/min 9 ). Postoperative complications included acute kidney injury (increase in serum creatinine of 0.3 mg/dL or 1.5-fold from baseline #48 hours 10 ), new need for hemodialysis (temporary or permanent), pneumonia (defined by new infiltrates on chest radiograph, leukocytosis, and noninvasive microbiology samples 11 ), respiratory failure (defined as failure to wean from mechanical ventilation #48 hours of surgery or unplanned intubation/reintubation postoperatively 12 ), bowel ischemia (defined as need for bowel ischemia due to presumed ischemic injury), stroke (defined as an acute neurologic resulting from an occlusive or hemorrhagic brain lesion), venous thromboembolic event (defined as deep vein thrombosis or pulmonary embolism, or both), bleeding requiring return to the operating room, lower extremity ischemia (defined as requiring a revascularization intervention), spinal headache (defined as severe headache requiring treatment in the setting of a spinal drain not attributable to other causes), heart failure (defined as severe pulmonary congestion attributable to elevated left-sided heart filling pressures, with or without a change in ejection fraction 13 ), myocardial infarction (defined as electrocardiogram changes with concomitant rise in serum troponin levels), surgical site infection (as defined by the Centers for Disease Control and Prevention 14 ), atrial fibrillation (confirmed by electrocardiogram), and paraplegia (defined as no movement, minimal motion, or flicker, or motion but not against resistance or gravity of the lower extremities 15 ). Routine postoperative follow-up consisted of annual computed tomography (CT) angiography scans in all patients with normal renal function. In patients with renal dysfunction, CT without contrast was used in combination with standard laboratory measurements (eg, creatinine, liver function tests) to assess for changes in branched graft patency. CT scans were reviewed again for this study to assess graft patency and new aneurysms whenever possible. Graft patency was classified as open or occluded in binary fashion; the presence of stenosis or kinks was not noted. Duplex ultrasound imaging was used to assess visceral-renal perfusion in all patients where renal function was altered compared with the previous visit. New aneurysms were defined as an arterial segment >1.5-times normal diameter that was not previously enlarged on the last available imaging. New aortic aneurysms were defined as aneurysms occurring in the aorta. New peripheral aneurysms included aneurysms occurring in the carotid, brachiocephalic, subclavian, or iliac arteries. New visceral-renal aneurysms were defined as aneurysms occurring in the visceral (celiac, superior mesenteric artery [SMA]) or renal arteries. New aneurysms were classified as being contiguous to the TAAA repair if they arose from the aortic, iliac, or visceral, or renal segment directly proximal or distal to the implanted graft.
ARTICLE HIGHLIGHTS
Operative technique. Our approach to open repair of TAAAs is standardized and depends on the cooperative efforts of a dedicated team of surgeons, anesthesiologists, perfusionists, nurses, surgical technicians, and intensivists. We have previously described our technique in detail, 6 but to summarize briefly, we predominantly use partial left-sided heart bypass with distal perfusion and sequential aortic clamping to minimize visceral ischemia time. Once the proximal anastomosis is performed, the infrarenal aorta is clamped, and the renal arteries are perfused with cold renal perfusion solution.
In our practice, we preferentially perform TAAA repairs with branched graft reconstruction because the visceralrenal ischemia time with this approach tends to be less than that required with inclusion patches. Branched graft anastomoses are relatively straightforward once the visceral segment of the aorta is isolated, and a series of 8-mm grafts can be connected more easily than creating what can be a challenging Carrel patch. In most cases, the renal arteries are reimplanted before the visceral arteries to reduce the duration of renal ischemia. The celiac and SMA are not routinely perfused from the circuit because these vessels are not routinely aneurysmal in the CTD population and may be at risk for dissection or rupture with cannulation.
The renal and visceral anastomoses are performed to separate branch grafts using the Vascutek Gelweave Plexus Graft (Vascutek Ltd, Renfrewshire, Scotland; Fig, A) , which is made for the aortic arch but adaptable for use in other types of aortic reconstruction, or the Vascutek Gelweave Coselli Thoracoabdominal Graft (Vascutek Ltd ; Fig, B ), which is made specifically for the thoracoabdominal aorta.
Motor-evoked potentials are used in all cases of left heart bypass to guide intercostal artery reimplantation; if motor-evoked potentials are lost after an intercoastal artery is clamped, that pair of arteries is included via a patch. More often, if motor-evoked potentials fade during an operation, a limited patch of T8-9 or T9-10 intercostal arteries may be implanted if the aorta is hospitable to suturing. We use preoperative spinal drain placement, sequential aortic clamping, and intercostal artery reimplantation using guidance from motorevoked potentials to reduce the perioperative risk of spinal cord ischemia in all patients. Postoperative outcomes, including perioperative morbidity and mortality, midterm graft patency, and the development of new aneurysms, were compared for patients with CTD vs degenerative disease. New aneurysms were classified as contiguous or noncontiguous with the original TAAA repair depending on the location: contiguous aneurysms were those that had connection with the original repair, whereas noncontiguous aneurysms were those that occurred in a separate location with a portion of normal aorta between it.
Descriptive data are summarized using mean 6 standard error of the mean for continuous variables with normal distributions, median (interquartile range) for continuous variables with non-normal distributions, and count (%) for categorical variables. Statistical analyses were performed using Student t tests for continuous variables and c 2 or Fisher exact tests for categoric variables.
JMP 12 software (SAS Institute Inc, Cary, NC) was used for all analyses. P < .05 was considered significant for all comparisons.
RESULTS
Baseline characteristics. During the 10-year study period, 137 patients underwent TAAA repair with branched graft reconstruction, including 29 with CTD and 108 with degenerative aneurysms. Among the CTD patients, the most common pathology was Marfan syndrome (n ¼ 23), followed by LDS (n ¼ 2), FTAAD (n ¼ 1), and CTD not otherwise specified (n ¼ 3). CTD patients were significantly younger (39.3 6 1.9 vs 68.2 6 1.0 years; P < .001) and had fewer comorbidities, including hypertension (44.8% vs 90.7%; P < .001), chronic obstructive pulmonary disease (6.9% vs 23.2%; P ¼ .05), and coronary artery disease (6.9% vs 24.1%; P ¼ .04) compared with patients with degenerative disease (Table I) . CTD patients also less frequently had a history of smoking (27.6% vs 75.9%; P < .001) and had lower preoperative creatinine values (0.8 6 0.1 vs 1.2 6 0.1 mg/dL; P ¼ .002), although the overall prevalence of preoperative renal insufficiency was not statistically different between groups (3.5% vs 12.0%; P ¼ .30). b-Blocker (96.6% vs 63.9%; P < .001) and angiotensin receptor blocker (51.7% vs 20.4%; P ¼ .002) use was more common among patients with CTD, whereas angiotensin-converting enzyme inhibitor (6.9% vs 34.3%; P ¼ .003), calcium channel blocker (17.2% vs 40.7%; P ¼ .02), and statin (27.6% vs 55.6%; P ¼ .008) use was more frequent compared with degenerative aneurysm patients (Table I) . Patients with CTD more commonly had a history of cardiovascular surgery (67.9% vs 39.8%; P ¼ .008) and a higher prevalence of aortic dissections (55.2% vs 15.7%; P < .001) and aneurysms involving the thoracic aorta (89.7% vs 60.2%; P ¼ .003) than patients with degenerative disease. Visceral (3.5% vs 7.4%) and iliac or other peripheral aneurysms (13.8% vs 13.9%) were similarly uncommon in both groups (P $ .68; Table II ).
Operative details. Most patients in the study underwent elective (nonemergent) TAAA repair, including 86.2% (n ¼ 25) of CTD patients and 82.4% (n ¼ 89) of non-CTD patients (P ¼ 78). Patients with CTD tended to undergo more extensive TAAA repairs than patients with degenerative aneurysms (P < .001; Table III) , and correspondingly required more branched grafts, with a mean number of grafts per patient of 3.27 6 0.20 vs 1.6 6 0.10 (P < .001). The proportion of patients who received a left renal artery graft was similar between groups (89.7% vs 83.3%; P ¼ .56), but celiac, SMA, and right renal artery grafts were all more common in patients with CTD (P < .001 for all; Table III ). CTD patients also had higher estimated blood loss (14.3 6 1.5 vs 6.1 6 0.7 L; P < .001) and required more red blood cells, plasma, platelet, and cellsaver transfusions compared with patients without CTD (P # .002 for all; Table III ). Perioperative outcomes. In-hospital mortality occurred in three CTD patients (10.0%) vs six degenerative aneurysm patients (5.6%; P ¼ .40). Of the CTD deaths, one patient died of sepsis in the setting of a significant chyle leak on postoperative day (POD) 32, one patient died of a hemorrhagic stroke (POD 7), and the third died after an aortic arch rupture proximal to the level of repair and clamping (POD 17). Of the acute degenerative aneurysm deaths, 2 were related to bowel ischemia (POD 2 and 11), 1 of whom had a visceral branch graft, 2 were the result of cardiovascular collapse in the setting of multiorgan system failure (POD 15 and 58), 1 was the result of endocarditis (POD 51), and the last was a patient with diffuse coagulopathy leading to uncontrollable hemorrhage (POD 1).
The overall incidence of perioperative complications was similar between groups (62.1% vs 54.6%; P ¼ .47). The most common perioperative complications were acute kidney injury (17.2% vs 19.4%), need for temporary hemodialysis (6.9% vs 13.9%), and pneumonia (10.3% vs 11.1%), all of which occurred with a similar frequency among CTD vs degenerative patients (P $ .53 for all; Table IV ). Bowel ischemia occurred in 8.3% of patients, all with degenerative aneurysms, but only 50% (3 of 6) of whom had undergone a visceral artery branched graft. Spinal cord injury was uncommon, with paralysis occurring in only one patient in each group (P ¼ .38). The incidence of acute branched graft thrombosis was not statistically different between the CTD and degenerative aneurysm groups (0% vs 6.5%; P ¼ .16). Midterm outcomes. At a median (IQR) follow-up time of 14.5 (6.5, 43.9) months, CTD patients were more likely to develop both new aortic (20.7%) and nonaortic (13.8%) aneurysms compared with the degenerative group (6.5% for aortic and 3.7% for nonaortic aneurysms). New aneurysms were contiguous with the TAAA repair in 66.7% CTD vs 63.6% degenerative patients (P ¼ .66). No branched grafts resulted in aneurysmal degeneration at the anastomosis. There was no significant correlation between the extent of the initial TAAA repair and the development of new contiguous aneurysms (P ¼ .95): in the CTD group, new contiguous aneurysms occurred in 6 patients, including 1 type I, 2 type II, 1 type III, 1 type IV, and 1 type V repair; in the degenerative group, new contiguous aneurysms occurred in 7 patients, including 1 type I, 1 type II, 1 type III, 3 type IV, and 1 type IV. The overall risk for developing a new aneurysm after TAAA repair with branched graft reconstruction was significantly higher for CTD patients (24.1% vs 8.3%; P ¼ .02). The incidence of new postoperative aortic dissections was similar between groups (3.5% vs 2.8%; P ¼ 1.0).
Loss of branch graft patency occurred in 0 of 98 grafts (0%) in CTD patients and in 13 of 167 grafts (7.8%) in degenerative disease patients (P ¼ .005). Loss of branch graft patency occurred most commonly in left renal artery bypass grafts (76.9% [n ¼ 10]), and was clinically asymptomatic. The most recent creatinine in degenerative patients was 1.4 6 0.1 vs 1.2 6 0.3 mg/dL at baseline (P ¼ .22), and no patients required new hemodialysis because of their branched graft thrombosis. Of note, most patients (n ¼ 103 [75.2%]) underwent CT angiography for branched graft surveillance.
DISCUSSION
We previously described our technique for using open branched graft reconstruction of aortic aneurysms and reported our favorable preliminary outcomes among a group of patients with CTDs. 6 However, the utility of this approach in the long-term, and among patients with aneurysms of degenerative origin, are unknown. In this report, we describe our institution's 10-year experience with open branched graft reconstruction of aortic aneurysms and compare our outcomes using this technique in patients with CTDs vs those with degenerative disease. We demonstrate that CTD patients tend to undergo more extensive repairs with more branched grafts than degenerative aneurysm patients. Despite this, we show that perioperative outcomes are similar between groups but that the midterm outcomes differ. In patients with CTD, there is a significant risk of developing new aortic aneurysms postoperatively. In contrast, patients with degenerative aneurysms are at higher risk for branched graft thrombosis. Taken together, these results reinforce the importance of postoperative imaging surveillance in both groups, though for different reasons.
We found that new aneurysms occurred in nearly onequarter of patients with CTD by a mean of 12 months postoperatively: new aortic aneurysms developed in 20%, and new peripheral aneurysms developed in 14%. These findings are in line with previous reports demonstrating that peripheral aneurysms are relatively common among patients with CTD. In a recent study by Gaertner et al, 16 67% of adult Marfan patients who underwent duplex ultrasound screening were found to have aneurysmal disease outside of thoracoabdominal aorta. Only one of the patients was symptomatic, and all were younger (age range, 27-44 years) than would standardly be expected for aneurysmal disease. Similarly, Yetman et al 17 demonstrated peripheral aneurysm disease in approximately one-third of Marfan patients as diagnosed by magnetic resonance or computer tomography imaging. Of these, dissection of the peripheral aneurysm occurred 68% and was fatal in 13%. 9 Peripheral aneurysms are common in patients with LDS, ED-IV, and FTAAD as well. 18 Based on these data, we conclude that the postoperative aneurysms observed within the CTD group in our study may be more the result of the disease process than a consequence of the aortic repair. Importantly, we did not identify any aneurysms involving the visceral-renal branches. Because CTD patients have a propensity for aneurysm formation of the aorta and elsewhere, whole-body surveillance is indicated to ensure early identification and allow for aggressive and proactive management, both before and after aortic repair. Appropriately, expert consensus guidelines currently recommend annual cardiovascular imaging surveillance of patients with Marfan syndrome, LDS, and other CTDs. 19, 20 In contrast to patients with CTD who undergo branched graft aortic reconstruction, patients with degenerative aneurysm disease who undergo the same procedure have a higher tendency to experience branched graft thrombosis. Although the exact mechanism for this risk is unclear, it may relate to the underlying risk factors for generalized atherosclerosis that are present in the degenerative aneurysm population. Smoking and coronary artery disease are significantly more common in this group compared to their CTD counterparts, both of which are associated with worse patency outcomes in nonaortic revascularizations. [21] [22] [23] [24] There are some data to suggest that smoking reduces nitric oxide bioavailability and increases expression of adhesion molecules, thereby leading to endothelial dysfunction, inflammation, and a hypercoagulable environment, which may play a role. 25 In addition, a high plaque burden is associated with worse outcomes after coronary artery bypass grafting, 26 supporting the concept that patients with atherosclerosis may also carry a higher risk for poor patency after branched graft reconstruction. The use of dual-antiplatelet therapy to reduce this risk in coronary artery bypass grafting patients has been debated, 27 but recent data suggest there is no benefit over the use of aspirin alone. 28 We do not routinely discharge patients on antiplatelet therapy aside from aspirin after branched graft aortic reconstruction, but perhaps the addition of clopidogrel or another antiplatelet agent to their regimen would be useful in improving our branch graft patency among patients with degenerative aneurysms in the future. Notably, 77% of branch graft thromboses occurred in left renal artery branch grafts. This could be a reflection of left renal artery kinking after reconstruction. When a proximal renal endarterectomy is performed, the tissues are so thin that the grafts are prone to kinking at the proximal aspect. To prevent this, we now tack Gerota's fascia to the dome of the diaphragm so the kidney does not slide down and accentuate the angle as a patient goes from a recumbent to a sitting position.
Although creating a very short graft from the aortic reconstruction to the renal-visceral target is enticing, the reconstruction will be difficult to roll and inspect for bleeding. In patients with CTD, we preferentially use the four-branch Plexus graft with the bypasses wrapped 270 around the graft (Fig, A) , or the Coselli graft with the branches arranged in an antegrade down-going configuration (Fig, B) . In both graft configurations, the bypass length may be 4 to 10 cm long. Importantly, despite the higher rate of thrombosis in the degenerative patients in our study, the clinical significance of the complication remained relatively low. Among all patients in our study, the morbidity after aortic branched graft reconstruction was consistent with prior literature, with an in-hospital mortality rate of 7% and perioperative complications occurring in 50% of patients overall. Previous reports of TAAA repair cite in-hospital mortality rates of 5% to 13%, and perioperative complication rates of 40% to 60%. 4, 29, 30 Although most of our patients fared well in the longterm, the immediate postoperative period after the repair carries a substantial risk for complications. In particular, a branched graft aortic reconstruction in a patient with CTD is associated with significant blood loss requiring large quantities of resuscitative product, both as a result of the poor tissue quality that these patients have 20 and the more extensive reconstructions that tend to be required. Certainly, CTD patients more frequently required type II or type III TAAA repairs, whereas type IV repairs were more common in the degenerative aneurysm group. The somewhat higher morbidity rate that we report compared with previously published TAA repair literature speaks to the challenging nature of the branched graft operation, and should reinforce the importance of appropriate patient selection when considering this technique.
Although the perioperative mortality was slightly higher in the CTD population in our experience, we have subsequently developed protocols to standardize the management of the related complications with great success. We now limit the amount of fluid drained hourly from the spinal drains to prevent subdural hematoma as the result of excess cerebrospinal fluid removal, with the understanding the bridging veins at risk for subdural hematoma may be more fragile in CTD patients. Indeed, for those patients with intact motor-evoked potentials intraoperatively and a robust motor examination on the morning after surgery, the lumbar drain is raised from the standard 10 cm H 2 O level to 15 cm H 2 O level to reduce drainage. We manage all chyle leaks with a strict no-fat diet vs a clear liquid diet in which even minimal fat can lead to ongoing chylothorax, its obligate neutropenia, and eventual sepsis. 31 Since the implementation of these protocols, we have observed no additional deaths related to postoperative stroke, central nervous system events, or chylothorax.
Making any firm comparative conclusions between the CTD and degenerative disease patients in our study is challenging because of the vast differences in baseline characteristics and disease pathology that exists between the two groups. Nevertheless, understanding how both populations fare after branched graft aortic reconstructions is informative because the differences in outcomes draw attention to how each group must be approached in a somewhat different manner.
Our study is also limited by a relatively small number of CTD patients; however, this is the largest series of CTD patients to date that we know of who have undergone branched graft aortic reconstruction, and therefore, our findings are useful as a preliminary platform off which we can base larger, perhaps multicenter or international studies.
In addition, we reported multiple outcomes (mortality, complications, branched graft patency, and new aneurysms) without formally correcting for multiple comparisons, which carries a risk of type I error.
Finally, we recognize that our outcomes are largely dependent on the successful integration of a specialized perioperative team consisting of surgeons, anesthesiologists, perfusionists, nurses, surgical technicians, and intensivists all trained in the care of CTD patients and intimately familiar with the technique of branched graft aortic reconstruction. 6 Thus, the data we present are likely not broadly generalizable to programs that do not have significant operative experience and postoperative protocols to manage the spectrum of events that can ensue. However, the surgical care of patients with advanced TAAA is important, and the general vascular surgeon can benefit from these data by gaining an understanding of the different reconstruction options available and how their application to different populations may affect outcomes in the long-term.
CONCLUSIONS
CTD patients with aortic aneurysms who undergo open branched graft reconstruction have reasonable outcomes compared with patients with degenerative pathology, including better branched graft patency and a similar risk of perioperative mortality and complications. Open repair of aortic aneurysms with branched graft reconstruction can be performed safely in both populations with low perioperative mortality, but ongoing surveillance is critical for the detection of new aneurysms, especially among patients with CTD. It appears that the extent of aortic disease was substantially different between the two patient cohorts, perhaps making a comparison of the groups problematic. Forty percent of patients with degenerative disease did not have thoracic involvement compared to only 10% in the connective tissue patient cohort. Patients with type IV thoracoabdominal aortic aneurysm repairs certainly have better outcome than those with more proximal disease. These patient cohorts were also treated differently regarding branches. At a mean branch graft use of 1.6 in the degenerative group, it sounds as though most patients received a left renal bypass and either a threevessel Carrel patch or a proximal bevel (for type IV patients). However, given a mean branch use of 3.3 in the connective tissue group, most visceral vessels were routinely branched in this patient cohort. The much higher prevalence of dissections and the 2.5-fold higher estimated blood loss in the connective tissue patient cohort both speak to the increased complexity of operative repair in these patients.
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I have three questions, and some editorial comment, for the authors:
One, what was the mortality rate between groups stratified to extent of disease? Taking out the type IVs and recalculating the mortality rate of the two groups would provide a more "apples-to-apples" comparison.
Two, it is intriguing that most of the branch occlusions were with the left renal. I find it sometimes challenging to gauge how that branch will lie once the left kidney and retroperitoneal contents are returned to their anatomic position; surely, the risk of kinking is elevated. Given your findings, has your group adopted a modified approach to improve left renal branch patency?
Three, your concluding sentence states: "connective tissue disorder patients with aortic aneurysm who undergo open branched graft reconstruction have favorable outcomes compared with patients with degenerative pathology." Do your really believe that, as the data, as presented, would suggest otherwise. While branched graft patency is a bit better for patients with connective tissue disease, the mortality rate is double, 10% vs 5.6%. Yes, that difference did not achieve statistical significance, but only because of the relatively low number (type II statistical error). Don't be a slave to the P value. Some outcome metrics can be statistically different but clinically irrelevant. Conversely, other variables may not reach statistical significance but have major clinical implications. Statistically better branch graft patency is irrelevant if twice as many patients are discharged to the morgue than to home. This is not to suggest that your results with the connective tissue patient cohort are subpardI believe they are remarkably good, given the complexity of the repairs and the fragility of the tissue.
In closing, I congratulate the Hopkins group in leading the way in defining the optimum treatment for thoracoabdominal aortic pathology in patients with connective tissue disorders. Outstanding work! Dr Caitlin W. Hicks. Thank you, Dr Sternbergh, for your questions. I will address each of them in order.
Regarding the question about whether mortality rates for the connective tissue patients vs those with degenerative aneurysms change if type IV thoracoabdominal aortic aneurysms are excludeddthe answer is no. As you saw in the data, approximately two-thirds of patients with degenerative thoracoabdominal aortic aneurysms (TAAAs) were type IV TAAAs, compared to a much lower proportion in the CTD group. Therefore, if we exclude all type IVs, the relative morality for CTD vs degenerative patients is approximately the same, but due to substantially lower number of cases in the analysis, the different is not statistically significant. We would need a much larger number of cases with similar TAAA anatomy before we would we be appropriately powered to detect a difference between the two groups and truly be able to compare "apples to apples."
Regarding your comment about the propensity for branched graft thromboses to involve the left renal vein, we certainly found this to be an interesting observation in our study. Especially in the degenerative aneurysm group, when a proximal renal endarterectomy is performed, the tissues are so thin that the grafts are prone to kinking at the level of the proximal artery. To avoid this, we now tack Gerota's fascia to the dome of the diaphragm so the kidney doesn't slide down and accentuate the graft angle. In the CTD group, we use the four-branch Plexus graft with the bypasses wrapped 270 around the graft, or the Coselli graft with the branches arranged in an antegrade down-going configuration, to avoid excess graft length and decrease the propensity for kinking. Anecdotally, we have had good results with these techniques. With respect to your concern about our conclusion that connective tissue disorder patients with aortic aneurysm who undergo open branched graft reconstruction have favorable outcomes compared with patients with degenerative pathologydwe admit that the relative mortality rates are clinically higher in the CTD group, but in reality, the 10% mortality rate within CTD patients includes only three deaths. None of those deaths were related to aortic issues involving the area of our repair; one patient died of a stroke, one died of an infected chylothorax, and the last died of an aortic arch rupture quite proximal to our repair. To address these issues, we have subsequently developed protocols to manage the major serious complications that affected these cases. We now have a spinal drain protocol that limits excess cerebrospinal fluid drainage to prevent subdural vein shearing and subsequent stroke that can occur in CTD patients. We also now have an established protocol whereby chyle leaks are managed with drainage and a strict no-fat diet. We have had good results with both of these changes, but perhaps it would be more accurate for us to conclude that connective tissue disorder patients with aortic aneurysms who undergo open branched graft reconstruction have reasonable outcomes compared with patients with degenerative pathology. It should be noted that all of the CTD deaths occurred early in our series, which speaks to the challenging nature of these repairs. Indeed, there is definitely a learning curve to performing TAAA repairs in general, and TAAA repairs in CTD patients specifically.
The favorable outcome that we have observed with branched grafted aortic reconstruction in patients with CTD is a low risk for branched graft thrombosis, which we consider a major benefit of this approach. While we don't suggest that our results are broadly translatable to a range of other institutions across the country, we hope that by sharing our experience we can initiate a conversation about the different approaches and subsequent challenges that accompany the management of complex open TAAA repairs in two unique patient populations.
